compounded tirzepatide shortage Update: On December 19th the FDA ruled the tirzepatide was resolved, however is giving a grace period for compounding pharmacies to continuing manufacturing. This grace period is 60 days. On A Major GLP-1 Drug Shortage

I recently returned from the largest peptide conference in the US, and let me tell you, the conversations shifted from this is miraculous, everyone should get it to it works for many under the right protocol. So lets unpack what GHK-Cu is, what it does, and where it might belong in a responsible, biology-informed healthspan strategy

However, this deadline could be extended, pending the outcome of ongoing court cases

Furthermore, alcohol can impair judgment and decision-making, potentially leading to medication non-adherence or unsafe behaviors

Special considerations for compounded tirzepatide and the thigh Compounded tirzepatide often comes in different concentrations and formulations compared to branded products

Clinical trials in Alzheimers disease Alzheimers disease is where the 2025 data forced the largest revision, and where the contrast between observational promise and trial outcome is sharpest